ANDA 83549, held by Ivax Sub Teva Pharms. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 83549 (Chlorpromazine Hydrochloride), held by Ivax Sub Teva Pharms, was first approved by FDA on May 6, 1974, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 6, 1974 | Original application | Approved | None posted |
| Chlorpromazine Hydrochloride10MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride25MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride50MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters